Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
15,024
archived clinical trials in
Infectious Disease

The Efficacy and Safety of Secukinumab in Patients With Ichthyoses
A Multicenter Study With a Randomized, Double-Blind, Placebo-Controlled Period, Followed by an Open-Label Maintenance Dosing Period to Evaluate the Efficacy and Safety of Secukinumab in Patients With Ichthyoses
Status: Enrolling
Updated:  12/31/1969
Department of Dermatology, Northwestern University Feinberg School of Medicine
mi
from
Chicago, IL
The Efficacy and Safety of Secukinumab in Patients With Ichthyoses
A Multicenter Study With a Randomized, Double-Blind, Placebo-Controlled Period, Followed by an Open-Label Maintenance Dosing Period to Evaluate the Efficacy and Safety of Secukinumab in Patients With Ichthyoses
Status: Enrolling
Updated: 12/31/1969
Department of Dermatology, Northwestern University Feinberg School of Medicine
mi
from
Chicago, IL
Click here to add this to my saved trials
The Efficacy and Safety of Secukinumab in Patients With Ichthyoses
A Multicenter Study With a Randomized, Double-Blind, Placebo-Controlled Period, Followed by an Open-Label Maintenance Dosing Period to Evaluate the Efficacy and Safety of Secukinumab in Patients With Ichthyoses
Status: Enrolling
Updated:  12/31/1969
Department of Dermatology Icahn School of Medicine at Mount Sinai
mi
from
New York, NY
The Efficacy and Safety of Secukinumab in Patients With Ichthyoses
A Multicenter Study With a Randomized, Double-Blind, Placebo-Controlled Period, Followed by an Open-Label Maintenance Dosing Period to Evaluate the Efficacy and Safety of Secukinumab in Patients With Ichthyoses
Status: Enrolling
Updated: 12/31/1969
Department of Dermatology Icahn School of Medicine at Mount Sinai
mi
from
New York, NY
Click here to add this to my saved trials
Kerlix Gauze Study in a Burn Trauma Unit and Its Effect on Healthcare Associated Infections in Burn Patients
Kerlix AMD Gauze Study In A Burn Trauma Unit and Its Effect on Healthcare Associated Infections in Burn Patients
Status: Enrolling
Updated:  12/31/1969
University of Iowa Hospitals and Clinics
mi
from
Iowa City, IA
Kerlix Gauze Study in a Burn Trauma Unit and Its Effect on Healthcare Associated Infections in Burn Patients
Kerlix AMD Gauze Study In A Burn Trauma Unit and Its Effect on Healthcare Associated Infections in Burn Patients
Status: Enrolling
Updated: 12/31/1969
University of Iowa Hospitals and Clinics
mi
from
Iowa City, IA
Click here to add this to my saved trials
M7824 in People With Recurrent Respiratory Papillomatosis
A Phase II Study of M7824 in Subjects With Recurrent Respiratory Papillomatosis
Status: Enrolling
Updated:  12/31/1969
National Institutes of Health Clinical Center
mi
from
Bethesda, MD
M7824 in People With Recurrent Respiratory Papillomatosis
A Phase II Study of M7824 in Subjects With Recurrent Respiratory Papillomatosis
Status: Enrolling
Updated: 12/31/1969
National Institutes of Health Clinical Center
mi
from
Bethesda, MD
Click here to add this to my saved trials
Study to Investigate Effect of Food and Safety of a New Formulation of Zoliflodacin
A Phase 1, Open-Label, Study to Investigate Pharmacokinetics, Effect of Food and Safety of a New Immediate-Release Formulation of Zoliflodacin in Healthy Subjects
Status: Enrolling
Updated:  12/31/1969
Quotient Sciences
mi
from
Miami, FL
Study to Investigate Effect of Food and Safety of a New Formulation of Zoliflodacin
A Phase 1, Open-Label, Study to Investigate Pharmacokinetics, Effect of Food and Safety of a New Immediate-Release Formulation of Zoliflodacin in Healthy Subjects
Status: Enrolling
Updated: 12/31/1969
Quotient Sciences
mi
from
Miami, FL
Click here to add this to my saved trials
Phase II Study Of Roferon and Accutane For Patients With T-Cell Malignancies
Phase II Study of Interferon Alpha and Isotretinoin in Patients With T-Cell Malignancies
Status: Enrolling
Updated:  12/31/1969
M D Anderson Cancer Center
mi
from
Houston, TX
Phase II Study Of Roferon and Accutane For Patients With T-Cell Malignancies
Phase II Study of Interferon Alpha and Isotretinoin in Patients With T-Cell Malignancies
Status: Enrolling
Updated: 12/31/1969
M D Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Early Bactericidal Activity of Linezolid, Gatifloxacin, Levofloxacin, Isoniazid (INH) and Moxifloxacin in HIV Negative Adults With Initial Episodes of Sputum Smear-Positive Pulmonary Tuberculosis
Randomized, Open Label, Multiple Dose Phase I Study of the Early Bactericidal Activity of Linezolid, Gatifloxacin, Levofloxacin, and Moxifloxacin in HIV-non-infected Adults With Initial Episodes of Sputum Smear-Positive Pulmonary Tuberculosis
Status: Enrolling
Updated:  12/31/1969
San Francisco General Hospital - Pulmonary and Critical Care Medicine
mi
from
San Francisco, CA
Early Bactericidal Activity of Linezolid, Gatifloxacin, Levofloxacin, Isoniazid (INH) and Moxifloxacin in HIV Negative Adults With Initial Episodes of Sputum Smear-Positive Pulmonary Tuberculosis
Randomized, Open Label, Multiple Dose Phase I Study of the Early Bactericidal Activity of Linezolid, Gatifloxacin, Levofloxacin, and Moxifloxacin in HIV-non-infected Adults With Initial Episodes of Sputum Smear-Positive Pulmonary Tuberculosis
Status: Enrolling
Updated: 12/31/1969
San Francisco General Hospital - Pulmonary and Critical Care Medicine
mi
from
San Francisco, CA
Click here to add this to my saved trials
Early Bactericidal Activity of Linezolid, Gatifloxacin, Levofloxacin, Isoniazid (INH) and Moxifloxacin in HIV Negative Adults With Initial Episodes of Sputum Smear-Positive Pulmonary Tuberculosis
Randomized, Open Label, Multiple Dose Phase I Study of the Early Bactericidal Activity of Linezolid, Gatifloxacin, Levofloxacin, and Moxifloxacin in HIV-non-infected Adults With Initial Episodes of Sputum Smear-Positive Pulmonary Tuberculosis
Status: Enrolling
Updated:  12/31/1969
Universidade Federal do Espirito Santo - Duke Hubert-Yeargan Center
mi
from
Vitória,
Early Bactericidal Activity of Linezolid, Gatifloxacin, Levofloxacin, Isoniazid (INH) and Moxifloxacin in HIV Negative Adults With Initial Episodes of Sputum Smear-Positive Pulmonary Tuberculosis
Randomized, Open Label, Multiple Dose Phase I Study of the Early Bactericidal Activity of Linezolid, Gatifloxacin, Levofloxacin, and Moxifloxacin in HIV-non-infected Adults With Initial Episodes of Sputum Smear-Positive Pulmonary Tuberculosis
Status: Enrolling
Updated: 12/31/1969
Universidade Federal do Espirito Santo - Duke Hubert-Yeargan Center
mi
from
Vitória,
Click here to add this to my saved trials
Combination Antibiotic Treatment for Reactive Arthritis Caused by Chlamydia Bacteria
Phase 3 Trial to Assess the Efficacy of Long-term (6 Months) Combination Antibiotics as a Treatment for Chlamydia-induced Reactive Arthritis
Status: Enrolling
Updated:  12/31/1969
University of South Florida
mi
from
Tampa, FL
Combination Antibiotic Treatment for Reactive Arthritis Caused by Chlamydia Bacteria
Phase 3 Trial to Assess the Efficacy of Long-term (6 Months) Combination Antibiotics as a Treatment for Chlamydia-induced Reactive Arthritis
Status: Enrolling
Updated: 12/31/1969
University of South Florida
mi
from
Tampa, FL
Click here to add this to my saved trials
Combination Antibiotic Treatment for Reactive Arthritis Caused by Chlamydia Bacteria
Phase 3 Trial to Assess the Efficacy of Long-term (6 Months) Combination Antibiotics as a Treatment for Chlamydia-induced Reactive Arthritis
Status: Enrolling
Updated:  12/31/1969
Louisiana State University
mi
from
New Orleans, LA
Combination Antibiotic Treatment for Reactive Arthritis Caused by Chlamydia Bacteria
Phase 3 Trial to Assess the Efficacy of Long-term (6 Months) Combination Antibiotics as a Treatment for Chlamydia-induced Reactive Arthritis
Status: Enrolling
Updated: 12/31/1969
Louisiana State University
mi
from
New Orleans, LA
Click here to add this to my saved trials
Combination Antibiotic Treatment for Reactive Arthritis Caused by Chlamydia Bacteria
Phase 3 Trial to Assess the Efficacy of Long-term (6 Months) Combination Antibiotics as a Treatment for Chlamydia-induced Reactive Arthritis
Status: Enrolling
Updated:  12/31/1969
University of Toronto
mi
from
Toronto,
Combination Antibiotic Treatment for Reactive Arthritis Caused by Chlamydia Bacteria
Phase 3 Trial to Assess the Efficacy of Long-term (6 Months) Combination Antibiotics as a Treatment for Chlamydia-induced Reactive Arthritis
Status: Enrolling
Updated: 12/31/1969
University of Toronto
mi
from
Toronto,
Click here to add this to my saved trials
HostDx Sepsis in the Diagnosis and Prognosis Patients With Acute Respiratory Infections
HostDx Sepsis in the Diagnosis and Prognosis of Emergency Department Patients With Acute Respiratory Infections: a Multicenter Pilot Study
Status: Enrolling
Updated:  12/31/1969
Inflammatix Inc
mi
from
Burlingame, CA
HostDx Sepsis in the Diagnosis and Prognosis Patients With Acute Respiratory Infections
HostDx Sepsis in the Diagnosis and Prognosis of Emergency Department Patients With Acute Respiratory Infections: a Multicenter Pilot Study
Status: Enrolling
Updated: 12/31/1969
Inflammatix Inc
mi
from
Burlingame, CA
Click here to add this to my saved trials
Increasing Human Papillomavirus (HPV) Vaccine Uptake Via General Health Messaging
Increasing Human Papillomavirus (HPV) Vaccine Uptake Via General Health Messaging
Status: Enrolling
Updated:  12/31/1969
University of California at Los Angeles
mi
from
Los Angeles, CA
Increasing Human Papillomavirus (HPV) Vaccine Uptake Via General Health Messaging
Increasing Human Papillomavirus (HPV) Vaccine Uptake Via General Health Messaging
Status: Enrolling
Updated: 12/31/1969
University of California at Los Angeles
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Evaluation of Safety and Reduction of Ear Pain in Adults With Acute Otitis Media and Reduction of Ear Pain in Adults With Acute Otitis Media
Evaluation of Safety and Reduction of Ear Pain in Adults With Acute Otitis Media
Status: Enrolling
Updated:  12/31/1969
US Clinical Research Group, LLC.
mi
from
Bellflower, CA
Evaluation of Safety and Reduction of Ear Pain in Adults With Acute Otitis Media and Reduction of Ear Pain in Adults With Acute Otitis Media
Evaluation of Safety and Reduction of Ear Pain in Adults With Acute Otitis Media
Status: Enrolling
Updated: 12/31/1969
US Clinical Research Group, LLC.
mi
from
Bellflower, CA
Click here to add this to my saved trials
Evaluation of Safety and Reduction of Ear Pain in Adults With Acute Otitis Media and Reduction of Ear Pain in Adults With Acute Otitis Media
Evaluation of Safety and Reduction of Ear Pain in Adults With Acute Otitis Media
Status: Enrolling
Updated:  12/31/1969
Vista Health Research, LLC
mi
from
Miami, FL
Evaluation of Safety and Reduction of Ear Pain in Adults With Acute Otitis Media and Reduction of Ear Pain in Adults With Acute Otitis Media
Evaluation of Safety and Reduction of Ear Pain in Adults With Acute Otitis Media
Status: Enrolling
Updated: 12/31/1969
Vista Health Research, LLC
mi
from
Miami, FL
Click here to add this to my saved trials
Evaluation of Safety and Reduction of Ear Pain in Adults With Acute Otitis Media and Reduction of Ear Pain in Adults With Acute Otitis Media
Evaluation of Safety and Reduction of Ear Pain in Adults With Acute Otitis Media
Status: Enrolling
Updated:  12/31/1969
Columbia University Medical Center
mi
from
New York, NY
Evaluation of Safety and Reduction of Ear Pain in Adults With Acute Otitis Media and Reduction of Ear Pain in Adults With Acute Otitis Media
Evaluation of Safety and Reduction of Ear Pain in Adults With Acute Otitis Media
Status: Enrolling
Updated: 12/31/1969
Columbia University Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Fever and Neutropenia in Pediatric Oncology Patients
Fever and Neutropenia in Pediatric Oncology Patients: A Randomized, Controlled, Multi-Center Study of Outpatient Therapy Evaluation of Genomic and Proteomic Correlates
Status: Enrolling
Updated:  12/31/1969
Children's Hospital Colorado
mi
from
Aurora, CO
Fever and Neutropenia in Pediatric Oncology Patients
Fever and Neutropenia in Pediatric Oncology Patients: A Randomized, Controlled, Multi-Center Study of Outpatient Therapy Evaluation of Genomic and Proteomic Correlates
Status: Enrolling
Updated: 12/31/1969
Children's Hospital Colorado
mi
from
Aurora, CO
Click here to add this to my saved trials
An Open-Label, Phase I, Escalating Dose Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of PDS0101
An Open-Label, Phase I, Escalating Dose Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of PDS0101 in Subjects With Cervical Intraepithelial Neoplasia (CIN) and High-risk Human Papillomavirus (HPV) Infection
Status: Enrolling
Updated:  12/31/1969
Montefiore Medical Center
mi
from
Bronx, NY
An Open-Label, Phase I, Escalating Dose Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of PDS0101
An Open-Label, Phase I, Escalating Dose Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of PDS0101 in Subjects With Cervical Intraepithelial Neoplasia (CIN) and High-risk Human Papillomavirus (HPV) Infection
Status: Enrolling
Updated: 12/31/1969
Montefiore Medical Center
mi
from
Bronx, NY
Click here to add this to my saved trials
An Open-Label, Phase I, Escalating Dose Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of PDS0101
An Open-Label, Phase I, Escalating Dose Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of PDS0101 in Subjects With Cervical Intraepithelial Neoplasia (CIN) and High-risk Human Papillomavirus (HPV) Infection
Status: Enrolling
Updated:  12/31/1969
Suffolk Obstetrics and Gynecology
mi
from
Port Jefferson, NY
An Open-Label, Phase I, Escalating Dose Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of PDS0101
An Open-Label, Phase I, Escalating Dose Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of PDS0101 in Subjects With Cervical Intraepithelial Neoplasia (CIN) and High-risk Human Papillomavirus (HPV) Infection
Status: Enrolling
Updated: 12/31/1969
Suffolk Obstetrics and Gynecology
mi
from
Port Jefferson, NY
Click here to add this to my saved trials
The Use of Probiotics to Evaluate Colonization With Antimicrobial Resistant Bacteria
The Use of the Probiotic, Lactobacillus Rhamnosus GG to Evaluate Colonization With Antimicrobial Resistant Bacteria in High Risk Patients
Status: Enrolling
Updated:  12/31/1969
Washington University School of Medicine
mi
from
Saint Louis, MO
The Use of Probiotics to Evaluate Colonization With Antimicrobial Resistant Bacteria
The Use of the Probiotic, Lactobacillus Rhamnosus GG to Evaluate Colonization With Antimicrobial Resistant Bacteria in High Risk Patients
Status: Enrolling
Updated: 12/31/1969
Washington University School of Medicine
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Evaluation of the Clinical Performance of the ZIKV Detect™ 2.0 IgM Capture ELISA
Evaluation of the Clinical Performance of the ZIKV Detect™ 2.0 IgM Capture ELISA
Status: Enrolling
Updated:  12/31/1969
InBios International
mi
from
Seattle, WA
Evaluation of the Clinical Performance of the ZIKV Detect™ 2.0 IgM Capture ELISA
Evaluation of the Clinical Performance of the ZIKV Detect™ 2.0 IgM Capture ELISA
Status: Enrolling
Updated: 12/31/1969
InBios International
mi
from
Seattle, WA
Click here to add this to my saved trials
Targeted Active Case Detection Among High Risk Populations in Southern Lao Peoples Democratic Republic
Assessing the Effectiveness of Targeted Active Case Detection Among High Risk Populations in Southern Lao PDR
Status: Enrolling
Updated:  12/31/1969
University of California at San Francisco
mi
from
San Francisco, CA
Targeted Active Case Detection Among High Risk Populations in Southern Lao Peoples Democratic Republic
Assessing the Effectiveness of Targeted Active Case Detection Among High Risk Populations in Southern Lao PDR
Status: Enrolling
Updated: 12/31/1969
University of California at San Francisco
mi
from
San Francisco, CA
Click here to add this to my saved trials
Targeted Active Case Detection Among High Risk Populations in Southern Lao Peoples Democratic Republic
Assessing the Effectiveness of Targeted Active Case Detection Among High Risk Populations in Southern Lao PDR
Status: Enrolling
Updated:  12/31/1969
Centre for Marialogy, Parasitology, and Entomology
mi
from
Vientiane,
Targeted Active Case Detection Among High Risk Populations in Southern Lao Peoples Democratic Republic
Assessing the Effectiveness of Targeted Active Case Detection Among High Risk Populations in Southern Lao PDR
Status: Enrolling
Updated: 12/31/1969
Centre for Marialogy, Parasitology, and Entomology
mi
from
Vientiane,
Click here to add this to my saved trials
Rice Bran Supplementation in Treated HIV Infection
Anti-Inflammatory Effects of Arabinoxylan Rice Bran Supplementation in Participants With Treated, Suppressed HIV Infection and Inadequate Immune Reconstitution
Status: Enrolling
Updated:  12/31/1969
Rand Schrader Health and Research Clinic
mi
from
Los Angeles, CA
Rice Bran Supplementation in Treated HIV Infection
Anti-Inflammatory Effects of Arabinoxylan Rice Bran Supplementation in Participants With Treated, Suppressed HIV Infection and Inadequate Immune Reconstitution
Status: Enrolling
Updated: 12/31/1969
Rand Schrader Health and Research Clinic
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Study to Evaluate Safety and Immunogenicity of One and Two Doses of IMVAMUNE® Smallpox Vaccine in 56-80 Year Old Vaccinia-experienced Subjects
A Randomized, Double-blind, Placebo-controlled Phase II Study to Evaluate Safety and Immunogenicity of One and Two Doses of IMVAMUNE® Smallpox Vaccine in 56-80 Year Old Vaccinia-experienced Subjects
Status: Enrolling
Updated:  12/31/1969
Orlando Clinical Research Center
mi
from
Orlando, FL
A Study to Evaluate Safety and Immunogenicity of One and Two Doses of IMVAMUNE® Smallpox Vaccine in 56-80 Year Old Vaccinia-experienced Subjects
A Randomized, Double-blind, Placebo-controlled Phase II Study to Evaluate Safety and Immunogenicity of One and Two Doses of IMVAMUNE® Smallpox Vaccine in 56-80 Year Old Vaccinia-experienced Subjects
Status: Enrolling
Updated: 12/31/1969
Orlando Clinical Research Center
mi
from
Orlando, FL
Click here to add this to my saved trials
A Study to Evaluate Safety and Immunogenicity of One and Two Doses of IMVAMUNE® Smallpox Vaccine in 56-80 Year Old Vaccinia-experienced Subjects
A Randomized, Double-blind, Placebo-controlled Phase II Study to Evaluate Safety and Immunogenicity of One and Two Doses of IMVAMUNE® Smallpox Vaccine in 56-80 Year Old Vaccinia-experienced Subjects
Status: Enrolling
Updated:  12/31/1969
University of Iowa
mi
from
Iowa City, IA
A Study to Evaluate Safety and Immunogenicity of One and Two Doses of IMVAMUNE® Smallpox Vaccine in 56-80 Year Old Vaccinia-experienced Subjects
A Randomized, Double-blind, Placebo-controlled Phase II Study to Evaluate Safety and Immunogenicity of One and Two Doses of IMVAMUNE® Smallpox Vaccine in 56-80 Year Old Vaccinia-experienced Subjects
Status: Enrolling
Updated: 12/31/1969
University of Iowa
mi
from
Iowa City, IA
Click here to add this to my saved trials
A Study to Evaluate Safety and Immunogenicity of One and Two Doses of IMVAMUNE® Smallpox Vaccine in 56-80 Year Old Vaccinia-experienced Subjects
A Randomized, Double-blind, Placebo-controlled Phase II Study to Evaluate Safety and Immunogenicity of One and Two Doses of IMVAMUNE® Smallpox Vaccine in 56-80 Year Old Vaccinia-experienced Subjects
Status: Enrolling
Updated:  12/31/1969
University of Kentucky, School of Medicine, Department of Medicine
mi
from
Lexington, KY
A Study to Evaluate Safety and Immunogenicity of One and Two Doses of IMVAMUNE® Smallpox Vaccine in 56-80 Year Old Vaccinia-experienced Subjects
A Randomized, Double-blind, Placebo-controlled Phase II Study to Evaluate Safety and Immunogenicity of One and Two Doses of IMVAMUNE® Smallpox Vaccine in 56-80 Year Old Vaccinia-experienced Subjects
Status: Enrolling
Updated: 12/31/1969
University of Kentucky, School of Medicine, Department of Medicine
mi
from
Lexington, KY
Click here to add this to my saved trials
A Study to Evaluate Safety and Immunogenicity of One and Two Doses of IMVAMUNE® Smallpox Vaccine in 56-80 Year Old Vaccinia-experienced Subjects
A Randomized, Double-blind, Placebo-controlled Phase II Study to Evaluate Safety and Immunogenicity of One and Two Doses of IMVAMUNE® Smallpox Vaccine in 56-80 Year Old Vaccinia-experienced Subjects
Status: Enrolling
Updated:  12/31/1969
Univ of Rochester Medical Center
mi
from
Rochester, NY
A Study to Evaluate Safety and Immunogenicity of One and Two Doses of IMVAMUNE® Smallpox Vaccine in 56-80 Year Old Vaccinia-experienced Subjects
A Randomized, Double-blind, Placebo-controlled Phase II Study to Evaluate Safety and Immunogenicity of One and Two Doses of IMVAMUNE® Smallpox Vaccine in 56-80 Year Old Vaccinia-experienced Subjects
Status: Enrolling
Updated: 12/31/1969
Univ of Rochester Medical Center
mi
from
Rochester, NY
Click here to add this to my saved trials
Prevention of HIV/AIDS and STDs in Women Over Fifty
Prevention of HIV/AIDS and STDs in Women Over Fifty
Status: Enrolling
Updated:  12/31/1969
Environment and Health Group
mi
from
Cambridge, MA
Prevention of HIV/AIDS and STDs in Women Over Fifty
Prevention of HIV/AIDS and STDs in Women Over Fifty
Status: Enrolling
Updated: 12/31/1969
Environment and Health Group
mi
from
Cambridge, MA
Click here to add this to my saved trials
Photodynamic Therapy Using Silicon Phthalocyanine 4 in Treating Patients With Actinic Keratosis, Bowen's Disease, Skin Cancer, or Stage I or Stage II Mycosis Fungoides
Phase I Clinical Trial Using Topical Silicon Phthalocyanine (Pc 4) Photodynamic Therapy (PDT) for the Treatment of Pre-Malignant and Malignant Skin Conditions
Status: Enrolling
Updated:  12/31/1969
University Hospitals Seidman Cancer Center
mi
from
Cleveland, OH
Photodynamic Therapy Using Silicon Phthalocyanine 4 in Treating Patients With Actinic Keratosis, Bowen's Disease, Skin Cancer, or Stage I or Stage II Mycosis Fungoides
Phase I Clinical Trial Using Topical Silicon Phthalocyanine (Pc 4) Photodynamic Therapy (PDT) for the Treatment of Pre-Malignant and Malignant Skin Conditions
Status: Enrolling
Updated: 12/31/1969
University Hospitals Seidman Cancer Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
CS DNA MVA Trial in Mampong, Ghana
A Phase I Trial of PFCSP DNA/MVA.CSO Prime/Boost Vaccine in Mampong, Ghana
Status: Enrolling
Updated:  12/31/1969
Naval Medical Research Center
mi
from
Silver Spring, MD
CS DNA MVA Trial in Mampong, Ghana
A Phase I Trial of PFCSP DNA/MVA.CSO Prime/Boost Vaccine in Mampong, Ghana
Status: Enrolling
Updated: 12/31/1969
Naval Medical Research Center
mi
from
Silver Spring, MD
Click here to add this to my saved trials
CS DNA MVA Trial in Mampong, Ghana
A Phase I Trial of PFCSP DNA/MVA.CSO Prime/Boost Vaccine in Mampong, Ghana
Status: Enrolling
Updated:  12/31/1969
Noguchi Memorial Institute of Medical Research
mi
from
Legon,
CS DNA MVA Trial in Mampong, Ghana
A Phase I Trial of PFCSP DNA/MVA.CSO Prime/Boost Vaccine in Mampong, Ghana
Status: Enrolling
Updated: 12/31/1969
Noguchi Memorial Institute of Medical Research
mi
from
Legon,
Click here to add this to my saved trials
TBTC Study 31: Rifapentine-containing Tuberculosis Treatment Shortening Regimens
Rifapentine-containing Treatment Shortening Regimens for Pulmonary Tuberculosis: A Randomized, Open-label, Controlled Phase 3 Clinical Trial. TBTC Study 31, ACTG Study A5349
Status: Enrolling
Updated:  12/31/1969
TBTC Site 82/ ACTG Site 801 USCF AIDS CRS
mi
from
San Francisco, CA
TBTC Study 31: Rifapentine-containing Tuberculosis Treatment Shortening Regimens
Rifapentine-containing Treatment Shortening Regimens for Pulmonary Tuberculosis: A Randomized, Open-label, Controlled Phase 3 Clinical Trial. TBTC Study 31, ACTG Study A5349
Status: Enrolling
Updated: 12/31/1969
TBTC Site 82/ ACTG Site 801 USCF AIDS CRS
mi
from
San Francisco, CA
Click here to add this to my saved trials
TBTC Study 31: Rifapentine-containing Tuberculosis Treatment Shortening Regimens
Rifapentine-containing Treatment Shortening Regimens for Pulmonary Tuberculosis: A Randomized, Open-label, Controlled Phase 3 Clinical Trial. TBTC Study 31, ACTG Study A5349
Status: Enrolling
Updated:  12/31/1969
TBTC Site 24 Columbia Unversity
mi
from
New York, NY
TBTC Study 31: Rifapentine-containing Tuberculosis Treatment Shortening Regimens
Rifapentine-containing Treatment Shortening Regimens for Pulmonary Tuberculosis: A Randomized, Open-label, Controlled Phase 3 Clinical Trial. TBTC Study 31, ACTG Study A5349
Status: Enrolling
Updated: 12/31/1969
TBTC Site 24 Columbia Unversity
mi
from
New York, NY
Click here to add this to my saved trials
TBTC Study 31: Rifapentine-containing Tuberculosis Treatment Shortening Regimens
Rifapentine-containing Treatment Shortening Regimens for Pulmonary Tuberculosis: A Randomized, Open-label, Controlled Phase 3 Clinical Trial. TBTC Study 31, ACTG Study A5349
Status: Enrolling
Updated:  12/31/1969
TBTC Site 20 UNTHSC (University of North Texas Health Science Center)
mi
from
Fort Worth, TX
TBTC Study 31: Rifapentine-containing Tuberculosis Treatment Shortening Regimens
Rifapentine-containing Treatment Shortening Regimens for Pulmonary Tuberculosis: A Randomized, Open-label, Controlled Phase 3 Clinical Trial. TBTC Study 31, ACTG Study A5349
Status: Enrolling
Updated: 12/31/1969
TBTC Site 20 UNTHSC (University of North Texas Health Science Center)
mi
from
Fort Worth, TX
Click here to add this to my saved trials
TBTC Study 31: Rifapentine-containing Tuberculosis Treatment Shortening Regimens
Rifapentine-containing Treatment Shortening Regimens for Pulmonary Tuberculosis: A Randomized, Open-label, Controlled Phase 3 Clinical Trial. TBTC Study 31, ACTG Study A5349
Status: Enrolling
Updated:  12/31/1969
TBTC Site 62 Baylor College of Medicine & Affiliated Hospitals/VA
mi
from
Houston, TX
TBTC Study 31: Rifapentine-containing Tuberculosis Treatment Shortening Regimens
Rifapentine-containing Treatment Shortening Regimens for Pulmonary Tuberculosis: A Randomized, Open-label, Controlled Phase 3 Clinical Trial. TBTC Study 31, ACTG Study A5349
Status: Enrolling
Updated: 12/31/1969
TBTC Site 62 Baylor College of Medicine & Affiliated Hospitals/VA
mi
from
Houston, TX
Click here to add this to my saved trials
TBTC Study 31: Rifapentine-containing Tuberculosis Treatment Shortening Regimens
Rifapentine-containing Treatment Shortening Regimens for Pulmonary Tuberculosis: A Randomized, Open-label, Controlled Phase 3 Clinical Trial. TBTC Study 31, ACTG Study A5349
Status: Enrolling
Updated:  12/31/1969
TBTC Site 63 San Antonio VA Medical Center (South Texas Group)
mi
from
San Antonio, TX
TBTC Study 31: Rifapentine-containing Tuberculosis Treatment Shortening Regimens
Rifapentine-containing Treatment Shortening Regimens for Pulmonary Tuberculosis: A Randomized, Open-label, Controlled Phase 3 Clinical Trial. TBTC Study 31, ACTG Study A5349
Status: Enrolling
Updated: 12/31/1969
TBTC Site 63 San Antonio VA Medical Center (South Texas Group)
mi
from
San Antonio, TX
Click here to add this to my saved trials
TBTC Study 31: Rifapentine-containing Tuberculosis Treatment Shortening Regimens
Rifapentine-containing Treatment Shortening Regimens for Pulmonary Tuberculosis: A Randomized, Open-label, Controlled Phase 3 Clinical Trial. TBTC Study 31, ACTG Study A5349
Status: Enrolling
Updated:  12/31/1969
TBTC Site 94/ ACTG Site 12201 Hospital Nossa Senhora da Conceicao
mi
from
Porto Alegre,
TBTC Study 31: Rifapentine-containing Tuberculosis Treatment Shortening Regimens
Rifapentine-containing Treatment Shortening Regimens for Pulmonary Tuberculosis: A Randomized, Open-label, Controlled Phase 3 Clinical Trial. TBTC Study 31, ACTG Study A5349
Status: Enrolling
Updated: 12/31/1969
TBTC Site 94/ ACTG Site 12201 Hospital Nossa Senhora da Conceicao
mi
from
Porto Alegre,
Click here to add this to my saved trials
Antibiotic Administration and Blood Culture Positivity in Severe Sepsis and Septic Shock
The Effect of Antibiotic Administration on Blood Culture Positivity in Patients With Severe Sepsis and Septic Shock: a Prospective Multicenter Observational Trial.
Status: Enrolling
Updated:  12/31/1969
Maricopa Integrated Health Center
mi
from
Phoenix, AZ
Antibiotic Administration and Blood Culture Positivity in Severe Sepsis and Septic Shock
The Effect of Antibiotic Administration on Blood Culture Positivity in Patients With Severe Sepsis and Septic Shock: a Prospective Multicenter Observational Trial.
Status: Enrolling
Updated: 12/31/1969
Maricopa Integrated Health Center
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Antibiotic Administration and Blood Culture Positivity in Severe Sepsis and Septic Shock
The Effect of Antibiotic Administration on Blood Culture Positivity in Patients With Severe Sepsis and Septic Shock: a Prospective Multicenter Observational Trial.
Status: Enrolling
Updated:  12/31/1969
Lions Gate Hospital
mi
from
North Vancouver,
Antibiotic Administration and Blood Culture Positivity in Severe Sepsis and Septic Shock
The Effect of Antibiotic Administration on Blood Culture Positivity in Patients With Severe Sepsis and Septic Shock: a Prospective Multicenter Observational Trial.
Status: Enrolling
Updated: 12/31/1969
Lions Gate Hospital
mi
from
North Vancouver,
Click here to add this to my saved trials
Use of an Electronic Medical Record in the Primary Care Setting to Improve Herpes Zoster Vaccination Rates
Use of an Electronic Medical Record to Improve Standard Practice in the Primary Care Setting: A Randomized-Controlled Study of Herpes Zoster Vaccination Rates
Status: Enrolling
Updated:  12/31/1969
The Ohio State University Martha Morehouse General Internal Medicine Clinic
mi
from
Columbus, OH
Use of an Electronic Medical Record in the Primary Care Setting to Improve Herpes Zoster Vaccination Rates
Use of an Electronic Medical Record to Improve Standard Practice in the Primary Care Setting: A Randomized-Controlled Study of Herpes Zoster Vaccination Rates
Status: Enrolling
Updated: 12/31/1969
The Ohio State University Martha Morehouse General Internal Medicine Clinic
mi
from
Columbus, OH
Click here to add this to my saved trials
Safety of and Immune Response to a Novel Human Papillomavirus Vaccine in HIV Infected Children
Phase II Safety and Immunogenicity Study of Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) L1 Virus-Like Particle (VLP) Vaccine in HIV Infected Children 7 to 12 Years of Age
Status: Enrolling
Updated:  12/31/1969
Usc La Nichd Crs
mi
from
Alhambra, CA
Safety of and Immune Response to a Novel Human Papillomavirus Vaccine in HIV Infected Children
Phase II Safety and Immunogenicity Study of Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) L1 Virus-Like Particle (VLP) Vaccine in HIV Infected Children 7 to 12 Years of Age
Status: Enrolling
Updated: 12/31/1969
Usc La Nichd Crs
mi
from
Alhambra, CA
Click here to add this to my saved trials
Safety of and Immune Response to a Novel Human Papillomavirus Vaccine in HIV Infected Children
Phase II Safety and Immunogenicity Study of Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) L1 Virus-Like Particle (VLP) Vaccine in HIV Infected Children 7 to 12 Years of Age
Status: Enrolling
Updated:  12/31/1969
Miller Children's Hosp. Long Beach CA NICHD CRS
mi
from
Long Beach, CA
Safety of and Immune Response to a Novel Human Papillomavirus Vaccine in HIV Infected Children
Phase II Safety and Immunogenicity Study of Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) L1 Virus-Like Particle (VLP) Vaccine in HIV Infected Children 7 to 12 Years of Age
Status: Enrolling
Updated: 12/31/1969
Miller Children's Hosp. Long Beach CA NICHD CRS
mi
from
Long Beach, CA
Click here to add this to my saved trials
Safety of and Immune Response to a Novel Human Papillomavirus Vaccine in HIV Infected Children
Phase II Safety and Immunogenicity Study of Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) L1 Virus-Like Particle (VLP) Vaccine in HIV Infected Children 7 to 12 Years of Age
Status: Enrolling
Updated:  12/31/1969
UCLA-Los Angeles/Brazil AIDS Consortium (LABAC) CRS
mi
from
Los Angeles, CA
Safety of and Immune Response to a Novel Human Papillomavirus Vaccine in HIV Infected Children
Phase II Safety and Immunogenicity Study of Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) L1 Virus-Like Particle (VLP) Vaccine in HIV Infected Children 7 to 12 Years of Age
Status: Enrolling
Updated: 12/31/1969
UCLA-Los Angeles/Brazil AIDS Consortium (LABAC) CRS
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Safety of and Immune Response to a Novel Human Papillomavirus Vaccine in HIV Infected Children
Phase II Safety and Immunogenicity Study of Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) L1 Virus-Like Particle (VLP) Vaccine in HIV Infected Children 7 to 12 Years of Age
Status: Enrolling
Updated:  12/31/1969
Children's Hospital of Orange County
mi
from
Orange, CA
Safety of and Immune Response to a Novel Human Papillomavirus Vaccine in HIV Infected Children
Phase II Safety and Immunogenicity Study of Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) L1 Virus-Like Particle (VLP) Vaccine in HIV Infected Children 7 to 12 Years of Age
Status: Enrolling
Updated: 12/31/1969
Children's Hospital of Orange County
mi
from
Orange, CA
Click here to add this to my saved trials
Safety of and Immune Response to a Novel Human Papillomavirus Vaccine in HIV Infected Children
Phase II Safety and Immunogenicity Study of Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) L1 Virus-Like Particle (VLP) Vaccine in HIV Infected Children 7 to 12 Years of Age
Status: Enrolling
Updated:  12/31/1969
UCSD Mother-Child-Adolescent Program CRS
mi
from
San Diego, CA
Safety of and Immune Response to a Novel Human Papillomavirus Vaccine in HIV Infected Children
Phase II Safety and Immunogenicity Study of Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) L1 Virus-Like Particle (VLP) Vaccine in HIV Infected Children 7 to 12 Years of Age
Status: Enrolling
Updated: 12/31/1969
UCSD Mother-Child-Adolescent Program CRS
mi
from
San Diego, CA
Click here to add this to my saved trials
Safety of and Immune Response to a Novel Human Papillomavirus Vaccine in HIV Infected Children
Phase II Safety and Immunogenicity Study of Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) L1 Virus-Like Particle (VLP) Vaccine in HIV Infected Children 7 to 12 Years of Age
Status: Enrolling
Updated:  12/31/1969
Univ. of California San Francisco NICHD CRS
mi
from
San Francisco, CA
Safety of and Immune Response to a Novel Human Papillomavirus Vaccine in HIV Infected Children
Phase II Safety and Immunogenicity Study of Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) L1 Virus-Like Particle (VLP) Vaccine in HIV Infected Children 7 to 12 Years of Age
Status: Enrolling
Updated: 12/31/1969
Univ. of California San Francisco NICHD CRS
mi
from
San Francisco, CA
Click here to add this to my saved trials
Safety of and Immune Response to a Novel Human Papillomavirus Vaccine in HIV Infected Children
Phase II Safety and Immunogenicity Study of Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) L1 Virus-Like Particle (VLP) Vaccine in HIV Infected Children 7 to 12 Years of Age
Status: Enrolling
Updated:  12/31/1969
Univ. of Colorado Denver NICHD CRS
mi
from
Aurora, CO
Safety of and Immune Response to a Novel Human Papillomavirus Vaccine in HIV Infected Children
Phase II Safety and Immunogenicity Study of Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) L1 Virus-Like Particle (VLP) Vaccine in HIV Infected Children 7 to 12 Years of Age
Status: Enrolling
Updated: 12/31/1969
Univ. of Colorado Denver NICHD CRS
mi
from
Aurora, CO
Click here to add this to my saved trials
Safety of and Immune Response to a Novel Human Papillomavirus Vaccine in HIV Infected Children
Phase II Safety and Immunogenicity Study of Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) L1 Virus-Like Particle (VLP) Vaccine in HIV Infected Children 7 to 12 Years of Age
Status: Enrolling
Updated:  12/31/1969
Connecticut Children's Medical Center
mi
from
Hartford, CT
Safety of and Immune Response to a Novel Human Papillomavirus Vaccine in HIV Infected Children
Phase II Safety and Immunogenicity Study of Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) L1 Virus-Like Particle (VLP) Vaccine in HIV Infected Children 7 to 12 Years of Age
Status: Enrolling
Updated: 12/31/1969
Connecticut Children's Medical Center
mi
from
Hartford, CT
Click here to add this to my saved trials
Safety of and Immune Response to a Novel Human Papillomavirus Vaccine in HIV Infected Children
Phase II Safety and Immunogenicity Study of Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) L1 Virus-Like Particle (VLP) Vaccine in HIV Infected Children 7 to 12 Years of Age
Status: Enrolling
Updated:  12/31/1969
Children's National Med. Ctr. Washington DC NICHD CRS
mi
from
Washington,
Safety of and Immune Response to a Novel Human Papillomavirus Vaccine in HIV Infected Children
Phase II Safety and Immunogenicity Study of Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) L1 Virus-Like Particle (VLP) Vaccine in HIV Infected Children 7 to 12 Years of Age
Status: Enrolling
Updated: 12/31/1969
Children's National Med. Ctr. Washington DC NICHD CRS
mi
from
Washington,
Click here to add this to my saved trials